Treatment Options for Sickle Cell Disease
This article focuses on supportive and preventive care improvements and the benefits of hydroxyurea. Indications for erythrocyte transfusion, hematopoietic stem cell transplant, and gene therapy trials are also summarized.
Source: Pediatric Clinics of North America - Category: Pediatrics Authors: Emily Riehm Meier Source Type: research
More News: Gene Therapy | Genetics | Pediatrics | Sickle Cell Anemia | Stem Cell Therapy | Stem Cells | Transplants